In addition, firm will establish Biomarker Center of Excellence in Indiana.
Covance purchased a minority equity stake in Caprion Proteomics to enhance its biomarker service offerings to clients.
Under the agreement, Covance will serve as the exclusive contract research organization distributor of Caprion’s proteomic biomarker services. In addition, Caprion will serve as Covance’s exclusive proteomic discovery provider.
To further accelerate and support the growth of its biomarker business, Covance plans to establish a Biomarker Center of Excellence at its campus in Greenfield, Indiana. The new center will focus specifically on biomarker testing and validation and leverage the discovery support services of Caprion and of the services that already reside at Greenfield, including in vivo preclinical safety and efficacy assessment, and a variety of sophisticated preclinical imaging modalities.
